Basic Information
| RNALocate ID: | RLID:11001995 |
| RNA Symbol: | hsa-miR-206 |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-206 |
| RNA ID: | miRBase:MIMAT0000462 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 18589210 |
| Tissue/Cell Line: | Primary ovarian tumor cells|Serum |
| Method: | MACS|Microarray |
| Description: | Exosomal miRNAs as potential biomarkers and therapeutic targets. Data are collected from Table 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001857 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:11001996 | Exosome | Brain tissue | 23382797 |
| RLID:11001997 | Exosome | Plasma | 23663360 |
| RLID-D:11000390 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells|Urine | |
| RLID-D:11001186 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-mir-206 | Inflammatory bowel disease | MNDR-E-MI-27228 |
| MNDR | hsa-mir-206 | Lymphoplasmacytic lymphoma | MNDR-E-MI-27229 |
| MNDR | hsa-mir-206 | Oral squamous cell carcinoma | MNDR-E-MI-27230 |
| MNDR | hsa-miR-206 | Oral squamous cell carcinoma | MNDR-E-MI-27231 |
| MNDR | hsa-miR-206 | Medulloblastoma | MNDR-E-MI-27232 |
| MNDR | hsa-mir-206 | Medulloblastoma | MNDR-E-MI-27233 |
| MNDR | hsa-miR-206 | Autism spectrum disorder | MNDR-E-MI-27234 |
| MNDR | hsa-miR-206 | Estrogen-receptor positive breast cancer | MNDR-E-MI-27235 |
| MNDR | hsa-miR-206 | Progesterone-receptor positive breast cancer | MNDR-E-MI-27236 |
| MNDR | hsa-miR-206 | Her2-receptor positive breast cancer | MNDR-E-MI-27237 |
| MNDR | hsa-miR-206 | Breast cancer luminal b | MNDR-E-MI-27238 |
| MNDR | hsa-miR-206 | Anencephaly | MNDR-E-MI-27239 |
| MNDR | hsa-mir-206 | Waldenstrom macroglobulinemia | MNDR-E-MI-27240 |
| MNDR | hsa-mir-206 | Miyoshi myopathy | MNDR-E-MI-27241 |
| MNDR | hsa-mir-206 | Colorectal carcinoma | MNDR-E-MI-27242 |
| MNDR | hsa-mir-206 | Melanoma and neural system tumor syndrome | MNDR-E-MI-27243 |
| MNDR | hsa-miR-206 | Dermatomyositis | MNDR-E-MI-27244 |
| MNDR | hsa-mir-206 | Dermatomyositis | MNDR-E-MI-27245 |
| MNDR | hsa-miR-206 | Prostate cancer | MNDR-E-MI-27246 |
| MNDR | hsa-mir-206 | Prostate cancer | MNDR-E-MI-27247 |
| MNDR | hsa-mir-206 | Chronic lymphocytic leukemia | MNDR-E-MI-27248 |
| MNDR | hsa-miR-206 | Hirschsprung disease | MNDR-E-MI-27249 |
| MNDR | hsa-mir-206 | Gastric cancer | MNDR-E-MI-27250 |
| MNDR | hsa-miR-206 | Gastric lymphoma | MNDR-E-MI-27251 |
| MNDR | hsa-miR-206 | Pre-eclampsia | MNDR-E-MI-27252 |
| MNDR | hsa-miR-206 | Alzheimer disease | MNDR-E-MI-27253 |
| MNDR | hsa-mir-206 | Alzheimer disease | MNDR-E-MI-27254 |
| MNDR | hsa-mir-206 | Sickle cell diseases | MNDR-E-MI-27255 |
| MNDR | hsa-miR-206 | Urinary bladder cancer | MNDR-E-MI-27256 |
| MNDR | hsa-miR-206 | Esophageal carcinoma | MNDR-E-MI-27257 |
| MNDR | hsa-mir-206 | Distal muscular dystrophy | MNDR-E-MI-27258 |
| MNDR | hsa-mir-206 | Myotonic dystrophy | MNDR-E-MI-27259 |
| MNDR | hsa-miR-206 | Myotonic dystrophy | MNDR-E-MI-27260 |
| MNDR | hsa-miR-206 | Duchenne muscular dystrophy | MNDR-E-MI-27261 |
| MNDR | hsa-mir-206 | Duchenne muscular dystrophy | MNDR-E-MI-27262 |
| MNDR | hsa-mir-206 | Leiomyoma | MNDR-E-MI-27263 |
| MNDR | hsa-miR-206 | Cardiovascular disease | MNDR-E-MI-27264 |
| MNDR | hsa-miR-206 | Dilated cardiomyopathy | MNDR-E-MI-27265 |
| MNDR | hsa-mir-206 | Lung cancer | MNDR-E-MI-27266 |
| MNDR | hsa-miR-206 | Lung cancer | MNDR-E-MI-27267 |
| MNDR | hsa-miR-206 | Facial paralysis | MNDR-E-MI-27268 |
| MNDR | hsa-miR-206 | Down syndrome | MNDR-E-MI-27269 |
| MNDR | hsa-miR-206 | Parkinson disease | MNDR-E-MI-27270 |
| MNDR | hsa-miR-206 | Cognitive dysfunction | MNDR-E-MI-27271 |
| MNDR | hsa-miR-206 | Basal-like breast cancer | MNDR-E-MI-27272 |
| MNDR | hsa-mir-206 | Breast cancer | MNDR-E-MI-27273 |
| MNDR | hsa-mir-206 | Cancer | MNDR-E-MI-27274 |
| MNDR | hsa-miR-206 | Thyroid cancer | MNDR-E-MI-27275 |
| MNDR | hsa-miR-206 | Pituitary neoplasms | MNDR-E-MI-27276 |
| MNDR | hsa-mir-206 | Pancreatic cancer | MNDR-E-MI-27277 |
| MNDR | hsa-miR-206 | Pancreatic cancer | MNDR-E-MI-27278 |
| MNDR | hsa-mir-206 | Malignant melanoma | MNDR-E-MI-27279 |
| MNDR | hsa-miR-206 | Melanoma | MNDR-E-MI-27280 |
| MNDR | hsa-miR-206 | Nephroblastoma | MNDR-E-MI-27281 |
| MNDR | hsa-miR-206 | Colon cancer | MNDR-E-MI-27282 |
| MNDR | hsa-miR-206 | Ischemic attack transient | MNDR-E-MI-27283 |
| MNDR | hsa-miR-206 | Multiple sclerosis relapsing-remitting | MNDR-E-MI-27284 |
| MNDR | hsa-mir-206 | Ovarian cancer | MNDR-E-MI-27285 |
| MNDR | hsa-miR-206 | Prostate adenocarcinoma | MNDR-E-MI-27286 |
| MNDR | hsa-mir-206 | Laryngeal neoplasms | MNDR-E-MI-27287 |
| MNDR | hsa-miR-206 | Mesothelioma | MNDR-E-MI-27288 |
| MNDR | hsa-mir-206 | Carcinoma endometrioid endometrial | MNDR-E-MI-27289 |
| MNDR | hsa-mir-206 | Laryngeal squamous cell carcinoma | MNDR-E-MI-27290 |
| MNDR | hsa-miR-206 | Pulmonary tuberculosis | MNDR-E-MI-27291 |
| MNDR | hsa-mir-206 | Glioblastoma | MNDR-E-MI-27292 |
| MNDR | hsa-miR-206 | Glioblastoma | MNDR-E-MI-27293 |
| MNDR | hsa-miR-206 | Astrocytoma | MNDR-E-MI-27294 |
| MNDR | hsa-miR-206 | Glioma | MNDR-E-MI-27295 |
| MNDR | hsa-mir-206 | Chronic obstructive pulmonary disease | MNDR-E-MI-27296 |
| MNDR | hsa-mir-206 | Rhabdomyosarcoma | MNDR-E-MI-27297 |
| MNDR | hsa-miR-206 | Rhabdomyosarcoma | MNDR-E-MI-27298 |
| MNDR | hsa-mir-206 | Amyotrophic lateral sclerosis | MNDR-E-MI-27299 |
| MNDR | hsa-miR-206 | Amyotrophic lateral sclerosis | MNDR-E-MI-27300 |
| MNDR | hsa-miR-206 | Osteosarcoma | MNDR-E-MI-27301 |
| MNDR | hsa-mir-206 | Osteosarcoma | MNDR-E-MI-27302 |
| MNDR | hsa-miR-206 | Coronary artery disease | MNDR-E-MI-27303 |
| MNDR | hsa-mir-206 | Carcinoma breast | MNDR-E-MI-27304 |
| MNDR | hsa-miR-206 | Pituitary adenoma | MNDR-E-MI-27305 |
| MNDR | hsa-mir-206 | Early-stage lung carcinoma | MNDR-E-MI-27306 |
| MNDR | hsa-miR-206 | Lung squamous cell carcinoma | MNDR-E-MI-27307 |
| MNDR | hsa-mir-206 | Carcinoma lung non-small-cell | MNDR-E-MI-27308 |
| MNDR | hsa-miR-206 | Lung adenocarcinoma | MNDR-E-MI-27309 |
| MNDR | hsa-mir-206 | Lung adenocarcinoma | MNDR-E-MI-27310 |
| MNDR | hsa-mir-206 | Pancreatic adenocarcinoma | MNDR-E-MI-27311 |
| MNDR | hsa-miR-206 | Pancreatic adenocarcinoma | MNDR-E-MI-27312 |
| MNDR | hsa-mir-206 | Muscle diseases | MNDR-E-MI-27313 |
| MNDR | hsa-miR-206 | Cervical cancer | MNDR-E-MI-27314 |
| MNDR | hsa-mir-206 | Cervical cancer | MNDR-E-MI-27315 |
| MNDR | hsa-mir-206 | Carcinoma renal cell | MNDR-E-MI-27316 |
| MNDR | hsa-miR-206 | Kidney chromophobe | MNDR-E-MI-27317 |
| MNDR | hsa-miR-206 | Kidney renal papillary cell carcinoma | MNDR-E-MI-27318 |
| MNDR | hsa-mir-206 | Clear cell renal cell cancer | MNDR-E-MI-27319 |
| MNDR | hsa-miR-206 | Clear cell renal cell carcinoma | MNDR-E-MI-27320 |
| MNDR | hsa-miR-206 | Cholangiocarcinoma | MNDR-E-MI-27321 |
| MNDR | hsa-miR-206 | Esophageal cancer | MNDR-E-MI-27322 |
| MNDR | hsa-mir-206 | Prolactinoma | MNDR-E-MI-27323 |
| MNDR | hsa-mir-206 | Schizophrenia | MNDR-E-MI-27324 |
| MNDR | hsa-miR-206 | Synovial sarcoma | MNDR-E-MI-27325 |
| MNDR | hsa-mir-206 | Head and neck squamous cell carcinoma | MNDR-E-MI-27326 |
| MNDR | hsa-miR-206 | Head and neck squamous cell carcinoma | MNDR-E-MI-27327 |
| MNDR | hsa-mir-206 | Myocardial infarction | MNDR-E-MI-27328 |
| MNDR | hsa-mir-206 | Epithelioid sarcoma | MNDR-E-MI-27329 |
| MNDR | hsa-mir-206 | Pulmonary arterial hypertension | MNDR-E-MI-27330 |
| MNDR | hsa-miR-206 | Hepatocellular carcinoma | MNDR-E-MI-27331 |
| MNDR | hsa-mir-206 | Hepatocellular carcinoma | MNDR-E-MI-27332 |
| MNDR | hsa-miR-206 | B-cell lymphoma | MNDR-E-MI-27333 |
| MNDR | hsa-miR-206 | T-cell leukemia | MNDR-E-MI-27334 |
| MNDR | hsa-miR-206 | Malignant pleural mesothelioma | MNDR-E-MI-27335 |
| MNDR | hsa-miR-206 | Neuroblastoma | MNDR-E-MI-27336 |
| MNDR | hsa-miR-206 | Burkitt lymphoma | MNDR-E-MI-27337 |
| MNDR | hsa-mir-206 | Thrombocytopenic purpurea autoimmune | MNDR-E-MI-27338 |
| MNDR | hsa-miR-206 | Colorectal cancer | MNDR-E-MI-27339 |
| MNDR | hsa-mir-206 | Colorectal cancer | MNDR-E-MI-27340 |
| MNDR | hsa-miR-206 | Nasopharynx carcinoma | MNDR-E-MI-27341 |
| MNDR | hsa-mir-206 | Muscular dystrophy | MNDR-E-MI-27342 |
| MNDR | hsa-mir-206 | Bronchopulmonary dysplasia | MNDR-E-MI-27343 |
| MNDR | hsa-mir-206 | Uterine cervical neoplasms | MNDR-E-MI-27344 |
| MNDR | hsa-mir-206 | Hypertrophy | MNDR-E-MI-27345 |
| MNDR | hsa-mir-206 | Inflammation | MNDR-E-MI-27346 |
| MNDR | hsa-mir-206 | Musculoskeletal abnormalities | MNDR-E-MI-27347 |
| MNDR | hsa-miR-206 | Nasopharyngeal cancer | MNDR-E-MI-27348 |
| MNDR | hsa-miR-206 | Prostatic neoplasms | MNDR-E-MI-27349 |
| MNDR | hsa-mir-206 | Synapses | MNDR-E-MI-27350 |
| MNDR | hsa-mir-206 | Systemic lupus erythematosus susceptibility | MNDR-E-MI-27351 |
| MNDR | hsa-mir-206 | Vascular hypertrophy | MNDR-E-MI-27352 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACTL6A | Homo sapiens | RR00037418 |
TOP